Total Payments
$10,265
2024 Payments
$272.41
Companies
37
Transactions
184
Medicare Patients
9,072
Medicare Billing
$1.5M
Payment Breakdown by Category
Consulting$6,345 (61.8%)
Food & Beverage$3,521 (34.3%)
Education$398.78 (3.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $6,345 | 4 | 61.8% |
| Food and Beverage | $3,521 | 175 | 34.3% |
| Education | $398.78 | 5 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $6,973 | 26 | $0 (2023) |
| Astellas Pharma US Inc | $417.55 | 6 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $390.02 | 20 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $319.55 | 20 | $0 (2024) |
| Amarin Pharma Inc. | $304.72 | 15 | $0 (2021) |
| Lilly USA, LLC | $178.84 | 10 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $160.19 | 3 | $0 (2022) |
| Dexcom, Inc. | $129.26 | 7 | $0 (2024) |
| ABBVIE INC. | $124.64 | 7 | $0 (2023) |
| GlaxoSmithKline, LLC. | $107.04 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $272.41 | 13 | Biosense Webster, Inc. ($67.90) |
| 2023 | $268.82 | 14 | AstraZeneca Pharmaceuticals LP ($78.21) |
| 2022 | $510.61 | 26 | Janssen Pharmaceuticals, Inc ($137.31) |
| 2021 | $2,984 | 56 | Novo Nordisk Inc ($1,839) |
| 2020 | $501.61 | 28 | Lilly USA, LLC ($97.87) |
| 2019 | $2,209 | 18 | Novo Nordisk Inc ($1,823) |
| 2018 | $3,303 | 14 | Novo Nordisk Inc ($3,101) |
| 2017 | $214.67 | 15 | AstraZeneca Pharmaceuticals LP ($62.47) |
All Payment Transactions
184 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Endocrinology | ||||||
| 11/15/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/07/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Diabetes Care | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Respiratory | ||||||
| 10/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Respiratory | ||||||
| 08/23/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Oncology | ||||||
| 08/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Respiratory | ||||||
| 05/31/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Endocrinology | ||||||
| 05/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Inflammation | ||||||
| 04/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Diabetes | ||||||
| 04/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/21/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $67.90 | General |
| Category: Cardiology | ||||||
| 03/08/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: PSYCHIATRY | ||||||
| 11/17/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/14/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: PSYCHIATRY | ||||||
| 10/04/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/02/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: RESPIRATORY | ||||||
| 09/15/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.57 | General |
| 07/17/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Diabetes Care | ||||||
| 06/23/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Cardiology | ||||||
| 06/10/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Diabetes | ||||||
| 06/08/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $28.74 | General |
| Category: NEUROLOGY | ||||||
| 05/03/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Diabetes | ||||||
| 04/14/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.76 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,743 | 4,322 | $560,651 | $313,220 |
| 2022 | 35 | 2,272 | 5,796 | $745,803 | $406,530 |
| 2021 | 34 | 2,377 | 5,383 | $674,930 | $369,034 |
| 2020 | 33 | 2,680 | 6,458 | $753,210 | $400,533 |
Total Patients
9,072
Total Services
21,959
Medicare Billing
$1.5M
Procedure Codes
131
All Medicare Procedures & Services
131 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 279 | 1,239 | $131,334 | $80,555 | 61.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 188 | 778 | $116,700 | $74,254 | 63.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 139 | 353 | $35,275 | $23,504 | 66.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 55 | 454 | $58,212 | $22,147 | 38.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 68 | 212 | $32,224 | $20,080 | 62.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 143 | 164 | $46,528 | $17,443 | 37.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 97 | 97 | $20,952 | $12,961 | 61.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 147 | 159 | $16,536 | $10,353 | 62.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 32 | 72 | $14,544 | $9,766 | 67.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 41 | 51 | $14,841 | $7,200 | 48.5% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 13 | 74 | $11,544 | $6,610 | 57.3% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 78 | 79 | $19,750 | $5,311 | 26.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 76 | 76 | $7,600 | $5,050 | 66.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 15 | 52 | $8,112 | $4,326 | 53.3% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 34 | 60 | $3,000 | $2,337 | 77.9% |
| 92552 | Test for hearing various pitches using earphone | Office | 2023 | 70 | 70 | $2,830 | $2,044 | 72.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 49 | $4,410 | $1,993 | 45.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 92 | 92 | $2,760 | $1,756 | 63.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $3,248 | $1,384 | 42.6% |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2023 | 22 | 25 | $2,000 | $1,257 | 62.9% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 13 | 27 | $1,755 | $923.67 | 52.6% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 37 | 38 | $2,926 | $843.98 | 28.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 12 | 12 | $1,140 | $517.20 | 45.4% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 18 | 18 | $720.00 | $291.96 | 40.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 19 | $1,140 | $227.81 | 20.0% |
About Dr. Imran Nathani, MD
Dr. Imran Nathani, MD is a Internal Medicine healthcare provider based in Tomball, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164495339.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Imran Nathani, MD has received a total of $10,265 in payments from pharmaceutical and medical device companies, with $272.41 received in 2024. These payments were reported across 184 transactions from 37 companies. The most common payment nature is "Consulting Fee" ($6,345).
As a Medicare-enrolled provider, Nathani has provided services to 9,072 Medicare beneficiaries, totaling 21,959 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 131 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Tomball, TX
- Active Since 02/08/2006
- Last Updated 09/08/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1164495339
Products in Payments
- Victoza (Drug) $4,923
- RYBELSUS (Drug) $1,662
- Vascepa (Drug) $304.72
- XARELTO (Drug) $289.74
- Ozempic (Drug) $266.88
- ELIQUIS (Drug) $172.63
- FARXIGA (Drug) $148.79
- TRULICITY (Drug) $127.21
- Rybelsus (Drug) $120.58
- VRAYLAR (Drug) $101.32
- DEXCOM G6 TRANSMITTER (Device) $92.59
- Kerendia (Drug) $79.68
- Tymlos (Biological) $68.36
- CARTO 3 (Device) $67.90
- BEVESPI AEROSPHERE (Drug) $58.18
- SPRAVATO (Drug) $55.34
- XIFAXAN (Drug) $55.15
- DALVANCE (Drug) $53.35
- NEXLETOL (Drug) $47.64
- INVOKANA (Drug) $44.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Tomball
Muhammad Irfan, M.d, M.D
Internal Medicine — Payments: $56,330
Internal Medicine $56,330
Shamaila Aslam, Md, MD
Internal Medicine — Payments: $23,675
Internal Medicine $23,675
Muhammad Motiwala, Md, MD
Internal Medicine — Payments: $11,194
Internal Medicine $11,194
Dr. Mark Le, M.d, M.D
Internal Medicine — Payments: $7,042
Internal Medicine $7,042
Dr. S Janel Beatie, Md, MD
Internal Medicine — Payments: $6,378
Internal Medicine $6,378
Amanbir Sohal, M.d, M.D
Internal Medicine — Payments: $6,139
Internal Medicine $6,139